HALO logo
halo search icon
Skye Bioscience, Inc.

US$0.77

Price Change Indicator
0.044 (6.04%)
Skye Bioscience, Inc.
SKYE · NAS

Skye Bioscience, Inc.

Start Trading SKYE for Free

US$0.77

Price Arrow0.044 (6.04%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Skye Bioscience, Inc. Overview

SKYE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About SKYE

icon

Website

Skye Bioscience, Inc.

icon

Telephone

icon

Address

Description

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.

SKYE Price Chart

Key Stats

Market Cap

US$25.56M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.57 - 5.75

Trade Value (12mth)

US$361,162.00

1 week

-10.87%

1 month

-12.11%

YTD

-17.42%

1 year

-67.19%

All time high

2750.00

Key Fundamentals

EPS 3 yr Growth

-83.90%

EBITDA Margin

0.00%

Operating Cashflow

-$43m

Free Cash Flow Return

-97.30%

ROIC

-126.30%

Interest Coverage

0.00

Quick Ratio

3.30

Other Data

Shares Outstanding (Fully Diluted)

40m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

SKYE Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
16 May 26
12 May 26
12 May 26

SKYE Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-5.37-0.73-1.41locklocklock
EPS (Fully Diluted)
 $locklocklocklock-5.37-0.73-1.41locklocklock
Growth
 %locklocklocklock38.786.4-93.7locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Skye Bioscience, Inc. (SKYE:NAS)?
Halo FAQ
The current share price of Skye Bioscience, Inc. (SKYE:NAS) is USD$0.77.
What is the 52-week high share price for Skye Bioscience, Inc. (SKYE:NAS)?
Halo FAQ
The 52-week high share price for Skye Bioscience, Inc. (SKYE:NAS) is USD$5.75.
What is the 52-week low share price for Skye Bioscience, Inc. (SKYE:NAS)?
Halo FAQ
The 52-week low share price for Skye Bioscience, Inc. (SKYE:NAS) is USD$0.57.
What is the dividend yield for Skye Bioscience, Inc. (SKYE:NAS)?
Halo FAQ
Skye Bioscience, Inc. (SKYE:NAS) does not pay a dividend.
What was Skye Bioscience, Inc. (SKYE:NAS) last dividend payment?
Halo FAQ
Skye Bioscience, Inc. (SKYE:NAS) does not pay a dividend.
What is the franking level for Skye Bioscience, Inc. (SKYE:NAS)?
Halo FAQ
Skye Bioscience, Inc. (SKYE:NAS) has a franking level of 0.00%.
In which sector is Skye Bioscience, Inc. (SKYE:NAS) classified?
Halo FAQ
Skye Bioscience, Inc. (SKYE:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial